This mdr is related to mdr 3013840437-2022-00028 referring to the same patient.
This spontaneous report was received form a german physician and concerns a female patient.
She was injected with a total of 1.
5 ml of radiesse(+), for an augmentation of the nasolabial folds, on (b)(6) 2022.
She was injected with 0.
75 ml on each side.
The patients medical history and concomitant medication were reported as none.
On (b)(6) 2022, after the radiesse(+) injection, the patient experienced an ischemia due to a compression of the supplying vessel.
On (b)(6) 2022, the patient reported this to her treating physician, who notified the reporter, on the same day, in the evening (ambiguously reported as (b)(6) 2022).
As corrective treatment, the patient received acetylsalicylic acid, warmth and 300 units of hyaluronidase.
The outcome of the events was reported as resolving.
|
This case was assessed as reportable to the fda, as the event ischemia due to a compression of the supplying vessel (pt: vascular compression), was deemed to meet the serious criteria of required intervention to prevent permanent damage.
The device history record of radiesse(+) injectable implant could not be reviewed, as the lot number was not reported.
|